# Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)

> **NCT06850870** · PHASE1 · RECRUITING · sponsor: **Onward Health, Inc** · enrollment: 120 (estimated)

## Conditions studied

- Alzheimer Disease or Associated Disorder
- Dementia
- Cognitive Decline

## Interventions

- **OTHER:** Door-through-door companion rideshare
- **OTHER:** Curb-to-curb rideshare services

## Key facts

- **NCT ID:** NCT06850870
- **Lead sponsor:** Onward Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2026-11-28
- **Final completion:** 2026-11-28
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06850870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06850870, "Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06850870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*